Independent. Trusted. Credible.


Industry collaboration for Australia’s genomics future

What's newGet involved



InGeNA is a single voice for Australian industry partners contributing to the rapidly developing field of genomics.

Alliance partners share a vision for Australia’s leadership in the adoption of genomics in healthcare.
– Better health outcomes
– Healthcare value and affordability
– A trusted, equitable and ethical genomics ecosystem

Collaboration across the key sectors of diagnostics/pathology, tech and pharma will ensure long and far-reaching benefits for Australian health consumers.

InGeNA the industry voice for the future of genomics in Australia


Join the first national industry led meeting in genomics bringing together the InGeNA industry alliance in genomics and other key stakeholders. HealthData21 will be held in Melbourne 27 – 28 May, with InGeNA presenting the program on day 1 focussed on “Integrating genomics into care”. Early bird registration is now open.


An industry alliance pulling together the Genomics ecosystem in Australia.

This webinar will introduce the InGeNA strategy, engagement and industry collaborations which aims to pull together the genomics ecosystem in Australia and give you a taste of what you’ll see at the HealthData21 conference.

Who we are

InGeNA was formed by a group of industry organisations, hosted by the Australasian Institute of Digital Health (AIDH), to bring a shared perspective on critically important areas underpinning the future of genomics.

  • A patient-centred approach
  • Digital infrastructure & principles
  • Workforce planning & skills
  • Government policy making

VISION Realising the full potential of genomics to personalise healthcare

MISSION To harness the collective skills and expertise of industry to integrate genomics into healthcare

Stay connected, stay informed! We welcome your interest. Complete this form to sign up for regular news, events and updates.



Collaborative projects


This venture has received funding through the MTPConnect Project Fund Program – a dollar-for-dollar matched program investing in big, bold ideas to improve the productivity, competitiveness and innovative capacity of Australia’s medical technology, biotechnology and pharmaceutical sector. MTPConnect is supported by the Australian Government Industry Growth Centres Initiative – learn more at

Chair Message

“We want Australians to have equity and access to the best that genomics can offer, now and in the future. With industry collaboration through InGeNA, there will be a single voice to have input into strategic planning, governance and funding directions through government, research centres and consumer health.”

David Bunker
InGeNA Chair


InGeNA News

Webinar introduces InGeNA alliance

Webinar introduces InGeNA alliance

This free public webinar will introduce InGeNA strategy, engagement and industry collaborations and offer a taste of what you’ll see at the HealthData21 conference. InGeNA will bring together industry experts from across Australia for the first time at...

read more
First digital genomics blueprint

First digital genomics blueprint

The Queensland Government working collaboratively with other health jurisdictions and research groups, has delivered the first digital genomics blueprint, which will serve as a national framework to support the management of genomic information and the...

read more
InGeNA contributing to public consultation

InGeNA contributing to public consultation

InGeNA is contributing to the Genomics Health Futures Mission (GHFM) public consultation on the Roadmap, Implementation Plan and Summary of Recommendations from the Scientific Strategy Committee Report. GHFM is a Mission of the Medical Research Future Fund...

read more

Genomics technology

The promise of genomics is to help Australians live longer and healthier lives by integrating genomics into the management of health and integrating genomics information and workflows into the health system.

The current focus of genomics is on using individual genetic information to inform tailored healthcare decisions.

Genomics is also expected to have a large impact at the population level in the future. Genomics has the potential to enable earlier diagnosis, improve the identification of the best treatment for the patient, and assist in disease prevention by analysing many genes or the entire genome (comprising all 22,000 genes present in human DNA) at once.




Contact Us


Level 1, 85 Buckhurst Street,
South Melbourne VIC 3205, Australia